Cancer Science 2019: Targeting pancreatic ductal adenocarcinoma with multi-peptide immunotherapy and repurposing drugs- Juan Pablo Marquez Manriquez- Sonora Cancer Research Center
tumor-characteristic and tumor outward factors lead to a disappointment in light of safe checkpoint inhibitor treatment. The distinguishing proof of biomarkers including mutational, neoantigen load and the PDL1…

